You are here

Eli Lilly

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries

Fierce Pharma

Mon, 03/27/23 - 11:23 am

clinical trials

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Motley Fool

Thu, 03/23/23 - 11:35 am

Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test

PM Live

Wed, 03/22/23 - 10:15 am

Alzheimer's disease

Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow

Fierce Biotech

Wed, 03/22/23 - 10:13 am

Flare Therapeutics

transcription factors

AACR 2023 – Moderna's immunotherapeutic splash

EP Vantage

Wed, 03/22/23 - 10:03 am

Moderna Therapeutics

Relay Therapeutics

Vivace Therapeutics

Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause

Medical Marketing and Media

Mon, 03/20/23 - 09:47 am

Daniel Skovronsky

Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs

Endpoints

Thu, 03/16/23 - 09:16 pm

SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance

Endpoints

Thu, 03/16/23 - 07:00 pm

Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly

BioSpace

Wed, 03/15/23 - 10:06 am

Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly

Forbes

Tue, 03/14/23 - 11:27 am

Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III

BioSpace

Thu, 03/9/23 - 11:46 am

Alzheimer's disease

clinical trials

Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro

Medical Marketing and Media

Thu, 03/9/23 - 11:26 am

Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med

Fierce Biotech

Tue, 03/7/23 - 11:45 am

Volastra Therapeutics

FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands

Fierce Pharma

Mon, 03/6/23 - 11:50 am

Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices

Fierce Pharma

Sun, 03/5/23 - 03:26 pm

Eli Lilly licenses non opioid pain med for $40M upfront

Seeking Alpha

Thu, 03/2/23 - 09:58 am

Confo Therapeutics

non-opioid pain treatments

Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance

CNBC

Wed, 03/1/23 - 10:10 am

Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report

Fierce Pharma

Tue, 02/28/23 - 10:39 pm

Boehringer Ingelheim

Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest

Fierce Pharma

Wed, 02/22/23 - 06:51 pm

Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival

Fierce Biotech

Wed, 02/15/23 - 10:48 am

Concert Pharmaceuticals

alopecia areata

breakthrough therapy

Pages